ADMA Biologics, Inc. (ADMA)
NASDAQ: ADMA · IEX Real-Time Price · USD
+0.18 (3.01%)
At close: Apr 16, 2024, 4:00 PM
-0.05 (-0.81%)
After-hours: Apr 16, 2024, 7:56 PM EDT

ADMA Biologics Revenue

In the year 2023, ADMA Biologics had annual revenue of $258.22M with 67.59% growth. Revenue in the quarter ending December 31, 2023 was $73.90M with 47.86% year-over-year growth.

Revenue (ttm)
Revenue Growth
P/S Ratio
Revenue / Employee
Market Cap
1.41B USD

Revenue Chart


Fiscal Year End Revenue Change Growth
Dec 31, 2023258.22M104.14M67.59%
Dec 31, 2022154.08M73.14M90.36%
Dec 31, 202180.94M38.72M91.72%
Dec 31, 202042.22M12.87M43.85%
Dec 31, 201929.35M12.36M72.79%
Dec 31, 201816.99M-5.78M-25.37%
Dec 31, 201722.76M12.10M113.49%
Dec 31, 201610.66M3.48M48.53%
Dec 31, 20157.18M1.26M21.34%
Dec 31, 20145.92M2.85M92.84%
Dec 31, 20133.07M1.95M174.35%
Dec 31, 20121.12M357.08K46.92%
Dec 31, 2011761.04K--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
AdaptHealth 3.20B
Agiliti 1.17B
National HealthCare 1.14B
Tilray Brands 743.25M
ANI Pharmaceuticals 486.82M
Zai Lab 266.72M
Establishment Labs Holdings 165.15M
Tarsus Pharmaceuticals 17.45M
Revenue Rankings